Specifically, we previously demonstrated that mice treated with the cell-penetrating Bin1 mAb protects against susceptibility to chemically-induced colitis, acting through several mechanisms to pleiotropically block colonic inflammation1–3. This evidence concerns the gene BIN1 and colitis.